Randomized controlled trials in psychiatry. Part 1: Methodology and critical evaluation

Australian and New Zealand Journal of Psychiatry

Volumn 37, Issue 3, 2003, Pages 257-264

  Porter, Richard ^a   Frampton, Chris ^a   Joyce, Peter R ^a   Mulder, Roger T ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Evidence based medicine; Psychopharmacology methods; Randomized controlled trials

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; IMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EVALUATION; HUMAN; METHODOLOGY; PATIENT SELECTION; PSYCHIATRY; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TREATMENT OUTCOME;

CYCLOHEXANOLS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; HUMANS; PATIENT SELECTION; PSYCHIATRY; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS;

EID: 0037626744     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2003.01175.x     Document Type: Article

References (18)

1. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association 1993; 270:2598-2601.
2. Benkert O, Grunder G, Wetzel H, Hackett D. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. Journal of Psychiatric Research 1996; 30:441-451.
3. Warner JP. Evidence-based psychopharmacology 1. Appraising a single therapeutic trial: what is the evidence for treating early Alzheimer's disease with donepezil? Journal of Psychopharmacology 1999; 13:308-312.
4. Lawrie SM. Randomised controlled trial. In: Brown T, Wilkinson G, eds. Critical reviews in psychiatry. London: Gaskell, 2000, 91-99.
5. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979; 134:382-389.
6. Schatzberg AF, Kraemer HC. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biological Psychiatry 2000; 47:736-744.
7. Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. Validity of clinical trials of antidepressants. American Journal of Psychiatry 2000; 157:327-337.
8. Trivedi MH, Rush H. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 1994; 11:33-43.
9. Miller FG. Placebo-controlled trials in psychiatric research: an ethical perspective. Biological Psychiatry 2000; 47:707-716.
10. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders 2000; 58:19-36.
11. Healy D. Psychopharmacology and the ethics of resource allocation. British Journal of Psychiatry 1993; 162:23-29; discussion 29-37.
12. McKenna PJ, Bailey P. The strange story of clozapine. British Journal of Psychiatry 1993; 162:32-37.
13. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23:56-62.
14. Balance. The balance trial. [Cited 4 March, 2003.] Available from URL: http://cebmh.warne.ox.ac.uk/balance/index.html
15. Swann AC, Bowden CL, Morris D et al. Depression during mania. Treatment response to lithium or divalproex. Archives of General Psychiatry 1997; 54:37-42.
16. Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P. The number needed to treat: a clinically useful nomogram in its proper context. British Medical Journal 1996; 312:426-429.
17. Thompson C. Amitriptyline. Still efficacious, but at what cost? British Journal of Psychiatry 2001; 178:99-100.
18. Anderson I. Lessons to be learnt from meta-analyses of newer versus older antidepressants. Advances in Psychiatric Treatment 1997; 3:58-63.